Location History:
- West Bengal, IN (2005 - 2010)
- Nadia, IN (2005 - 2010)
Company Filing History:
Years Active: 2005-2010
Title: Subrata Sarkar: Innovator in Pharmaceutical Chemistry
Introduction
Subrata Sarkar is a notable inventor in the field of pharmaceutical chemistry, particularly recognized for his contributions to anticancer drug development. He is based in Nadia, India, and has been granted a total of 7 patents for his innovative work.
Latest Patents
One of his latest patents is titled "Method of preparation of anticancer taxanes using 3-[(substituted-2-trialkylsilyl)ethoxy-carbonyl]-5-oxazolidine carboxylic acids." This invention outlines a process for preparing taxanes by subjecting specific intermediates to a series of chemical reactions, ultimately leading to the production of paclitaxel or docetaxel, which are vital in cancer treatment. Another significant patent involves the "Metaxalone polymorphs," which provides two bioavailable crystalline forms of the skeletal muscle relaxant Metaxalone, along with a process for their preparation. These forms are designed to alleviate discomfort associated with acute musculoskeletal conditions.
Career Highlights
Throughout his career, Subrata Sarkar has worked with prominent companies such as Dabur India Limited and Fresenius Kabi Oncology Limited. His experience in these organizations has significantly contributed to his expertise in pharmaceutical innovations.
Collaborations
He has collaborated with notable colleagues, including Arun Prakash Sharma and Jyan Shankar Mahanty, which has further enriched his research and development efforts.
Conclusion
Subrata Sarkar's contributions to pharmaceutical chemistry, particularly in anticancer drug development, highlight his innovative spirit and dedication to improving healthcare solutions. His patents reflect a commitment to advancing medical science and providing effective treatments for patients.